XBiotech Inc. SEC filings XBIT

XBiotech Inc. has 407 filings in SEC EDGAR's recent list, going back to Dec 10, 2014. Its latest annual report, Form ARS, was filed on Oct 2, 2026 for the period ended Oct 2, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (officer or director change). The company's fiscal year ends on December 31.

Form Description Filed Period
S-8 Employee stock plan registration Mar 11, 2026 —
S-8 Employee stock plan registration Oct 2, 2020 —
424B5 Prospectus supplement Jun 3, 2019 —
S-3MEF Form s-3 May 31, 2019 —
424B5 Prospectus supplement May 31, 2019 —
424B5 Prospectus supplement May 1, 2019 —
424B5 Prospectus supplement Mar 3, 2017 —
424B5 Prospectus supplement Sep 26, 2016 —
S-3 Shelf registration Aug 19, 2016 —
S-8 Employee stock plan registration Oct 19, 2015 —
424B4 Prospectus Apr 16, 2015 —
S-1/A Amended registration statement Apr 10, 2015 —
FWP Free writing prospectus Mar 27, 2015 —
FWP Free writing prospectus Mar 27, 2015 —
S-1/A Amended registration statement Mar 27, 2015 —
S-1/A Amended registration statement Mar 10, 2015 —
S-1 Registration statement Feb 2, 2015 —

Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
XBIT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
British Columbia, Canada
Headquarters
Austin, TX
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1626878

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.